STERIS Share Holder Equity 2010-2022 | STE

STERIS share holder equity from 2010 to 2022. Share holder equity can be defined as the sum of preferred and common equity items
  • STERIS share holder equity for the quarter ending December 31, 2022 was $6.049B, a 8.68% decline year-over-year.
  • STERIS share holder equity for 2022 was $6.545B, a 68.18% increase from 2021.
  • STERIS share holder equity for 2021 was $3.891B, a 13.85% increase from 2020.
  • STERIS share holder equity for 2020 was $3.418B, a 7.3% increase from 2019.
STERIS Annual Share Holder Equity
(Millions of US $)
2022 $6,545
2021 $3,891
2020 $3,418
2019 $3,186
2018 $3,217
2017 $2,810
2016 $3,039
2015 $1,074
2014 $1,041
2013 $947
2012 $823
2011 $789
2010 $754
2009 $718
STERIS Quarterly Share Holder Equity
(Millions of US $)
2022-12-31 $6,049
2022-09-30 $5,813
2022-06-30 $6,419
2022-03-31 $6,545
2021-12-31 $6,624
2021-09-30 $6,545
2021-06-30 $6,585
2021-03-31 $3,891
2020-12-31 $3,878
2020-09-30 $3,662
2020-06-30 $3,490
2020-03-31 $3,418
2019-12-31 $3,396
2019-09-30 $3,238
2019-06-30 $3,245
2019-03-31 $3,186
2018-12-31 $3,112
2018-09-30 $3,125
2018-06-30 $3,099
2018-03-31 $3,217
2017-12-31 $3,118
2017-09-30 $3,041
2017-06-30 $2,939
2017-03-31 $2,810
2016-12-31 $2,770
2016-09-30 $3,010
2016-06-30 $3,048
2016-03-31 $3,039
2015-12-31 $2,990
2015-09-30 $1,092
2015-06-30 $1,100
2015-03-31 $1,074
2014-12-31 $1,076
2014-09-30 $1,068
2014-06-30 $1,066
2014-03-31 $1,041
2013-12-31 $1,010
2013-09-30 $991
2013-06-30 $971
2013-03-31 $947
2012-12-31 $920
2012-09-30 $882
2012-06-30 $833
2012-03-31 $823
2011-12-31 $780
2011-09-30 $777
2011-06-30 $816
2011-03-31 $789
2010-12-31 $751
2010-09-30 $730
2010-06-30 $696
2010-03-31 $754
2009-12-31 $733
2009-09-30 $801
2009-06-30 $764
2009-03-31 $718
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $17.996B $4.585B
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $212.206B 23.69
Edwards Lifesciences (EW) United States $49.143B 32.69
Alcon (ALC) Switzerland $32.311B 29.57
Fresenius Medical Care AG KGaA (FMS) Germany $11.408B 11.93
Teleflex (TFX) United States $11.141B 18.17
Penumbra (PEN) United States $10.162B 1565.71
Globus Medical (GMED) United States $5.255B 25.31
Integer Holdings (ITGR) United States $2.448B 18.98
Glaukos (GKOS) United States $2.324B 0.00
Paragon 28 (FNA) United States $1.527B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.330B 17.30
Nevro (NVRO) United States $1.089B 0.00
Artivion (AORT) United States $0.488B 240.60